XML 26 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
Derivative Financial Instruments
3 Months Ended
Feb. 28, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments
Derivative Financial Instruments
Off-Balance Sheet Risk
We have contractual commitments arising in the ordinary course of business for securities loaned or purchased under agreements to resell, repurchase agreements, future purchases and sales of foreign currencies, securities transactions on a when-issued basis and underwriting. Each of these financial instruments and activities contains varying degrees of off-balance sheet risk whereby the fair values of the securities underlying the financial instruments may be in excess of, or less than, the contract amount. The settlement of these transactions is not expected to have a material effect upon our consolidated financial statements.
Derivative Financial Instruments
Our derivative activities are recorded at fair value in the Consolidated Statements of Financial Condition in Financial instruments owned and Financial instruments sold, not yet purchased, net of cash paid or received under credit support agreements and on a net counterparty basis when a legally enforceable right to offset exists under a master netting agreement. Predominantly, we enter into derivative transactions to satisfy the needs of our clients and to manage our own exposure to market and credit risks resulting from our trading activities. In addition, we apply hedge accounting to an interest rate swap that has been designated as a fair value hedge of the changes in fair value due to the benchmark interest rate for certain fixed rate senior long-term debt.
See Note 4, Fair Value Disclosures, and Note 16, Commitments, Contingencies and Guarantees, for additional disclosures about derivative financial instruments.
Derivatives are subject to various risks similar to other financial instruments, including market, credit and operational risk. The risks of derivatives should not be viewed in isolation, but rather should be considered on an aggregate basis along with our other trading-related activities. We manage the risks associated with derivatives on an aggregate basis along with the risks associated with proprietary trading as part of our firm wide risk management policies.
In connection with our derivative activities, we may enter into ISDA master netting agreements or similar agreements with counterparties. See Note 2, Summary of Significant Accounting Policies, for additional information regarding the offsetting of derivative contracts.
The following tables present the fair value and related number of derivative contracts at February 28, 2017 and November 30, 2016 categorized by type of derivative contract and the platform on which these derivatives are transacted. The fair value of assets/liabilities represents our receivable/payable for derivative financial instruments, gross of counterparty netting and cash collateral received and pledged. The following tables also provide information regarding 1) the extent to which, under enforceable master netting arrangements, such balances are presented net in the Consolidated Statements of Financial Condition as appropriate under U.S. GAAP and 2) the extent to which other rights of setoff associated with these arrangements exist and could have an effect on our financial position (in thousands, except contract amounts).
 
February 28, 2017 (1)
 
Assets
 
Liabilities
 
Fair Value
 
Number of Contracts
 
Fair Value
 
Number of Contracts
Derivatives designated as accounting hedges:
 
 
 
 
 
 
 
Interest rate contracts:
 
 
 
 
 
 
 
Cleared OTC
$

 

 
$
3,456

 
1

Total derivatives designated as accounting hedges

 
 
 
3,456

 
 
 
 
 
 
 
 
 
 
Derivatives not designated as accounting hedges:
 
 
 
 
 
 
 
Interest rate contracts:
 
 
 
 
 
 
 
Exchange-traded
2,797

 
23,014

 
635

 
41,259

Cleared OTC
1,715,306

 
3,258

 
1,604,811

 
3,301

Bilateral OTC
360,402

 
1,524

 
366,006

 
682

Foreign exchange contracts:
 
 
 
 
 
 
 
Exchange-traded
140

 
734

 
3

 
431

Bilateral OTC
308,556

 
5,797

 
300,816

 
5,971

Equity contracts:
 
 
 
 
 
 
 
Exchange-traded
537,971

 
1,822,926

 
773,258

 
1,595,727

Bilateral OTC
65,189

 
1,139

 
91,216

 
1,367

Commodity contracts:
 
 
 
 
 
 
 
Exchange-traded
7

 
4,851

 

 
4,711

Credit contracts:
 
 
 
 
 
 
 
Cleared OTC
3,071

 
23

 
12,555

 
34

Bilateral OTC
19,826

 
191

 
15,257

 
122

Total derivatives not designated as hedges
3,013,265

 
 
 
3,164,557

 
 
 
 
 
 
 
 
 
 
Total gross derivative assets/ liabilities:
 
 
 
 
 
 
 
Exchange-traded
540,915

 
 
 
773,896

 

Cleared OTC
1,718,377

 
 
 
1,620,822

 

Bilateral OTC
753,973

 
 
 
773,295

 

Amounts offset in the Consolidated Statements of Financial Condition (2):
 
 
 
 
 
 
 
Exchange-traded
(526,103
)
 
 
 
(526,103
)
 
 
Cleared OTC
(1,701,815
)
 
 
 
(1,608,805
)
 
 
Bilateral OTC
(598,845
)
 
 
 
(659,524
)
 
 
Net amounts per Consolidated Statements of Financial Condition (3)
$
186,502

 
 
 
$
373,581

 
 
(1)
Exchange-traded derivatives include derivatives executed on an organized exchange. Cleared OTC derivatives include derivatives executed bilaterally and subsequently novated to and cleared through central clearing counterparties. Bilateral OTC derivatives include derivatives executed and settled bilaterally without the use of an organized exchange or central clearing counterparty.
(2)
Amounts netted include both netting by counterparty and for cash collateral paid or received.
(3)
We have not received or pledged additional collateral under master netting agreements and/or other credit support agreements that is eligible to be offset beyond what has been offset in the Consolidated Statements of Financial Condition.
 
November 30, 2016 (1)
 
Assets
 
Liabilities
 
Fair Value
 
Number of Contracts
 
Fair Value
 
Number of Contracts
Derivatives not designated as accounting hedges:
 
 
 
 
 
 
 
Interest rate contracts:
 
 
 
 
 
 
 
Exchange-traded
$
2,275

 
24,300

 
$
24

 
29,773

Cleared OTC
2,835,812

 
3,596

 
2,636,469

 
3,445

Bilateral OTC
444,159

 
1,136

 
522,965

 
1,627

Foreign exchange contracts:
 
 
 
 
 
 
 
Exchange-traded

 
376

 

 
686

Bilateral OTC
529,609

 
7,448

 
516,869

 
7,633

Equity contracts:
 
 
 
 
 
 
 
Exchange-traded
712,767

 
2,820,702

 
1,095,582

 
2,410,956

Bilateral OTC
72,041

 
1,077

 
67,033

 
1,191

Commodity contracts:
 
 
 
 
 
 
 
Exchange-traded

 
1,356

 

 
920

Credit contracts:
 
 
 
 
 
 
 
Cleared OTC
645

 
6

 
2,304

 
8

Bilateral OTC
19,225

 
213

 
25,503

 
184

Total gross derivative assets/liabilities:
 
 
 
 
 
 
 
Exchange-traded
715,042

 
 
 
1,095,606

 
 
Cleared OTC
2,836,457

 
 
 
2,638,773

 
 
Bilateral OTC
1,065,034

 
 
 
1,132,370

 
 
Amounts offset in the Consolidated Statements of Financial Condition (2):
 
 
 
 
 
 
 
Exchange-traded
(691,009
)
 
 
 
(691,009
)
 
 
Cleared OTC
(2,751,650
)
 
 
 
(2,638,774
)
 
 
Bilateral OTC
(813,340
)
 
 
 
(899,431
)
 
 
Net amounts per Consolidated Statements of Financial Condition (3)
$
360,534

 
 
 
$
637,535

 
 
(1)
Exchange-traded derivatives include derivatives executed on an organized exchange. Cleared OTC derivatives include derivatives executed bilaterally and subsequently novated to and cleared through central clearing counterparties. Bilateral OTC derivatives include derivatives executed and settled bilaterally without the use of an organized exchange or central clearing counterparty.
(2)
Amounts netted include both netting by counterparty and for cash collateral paid or received.
(3)
We have not received or pledged additional collateral under master netting agreements and/or other credit support agreements that is eligible to be offset beyond what has been offset in the Consolidated Statements of Financial Condition.
The following table provides information related to gains (losses) recognized in Interest expense in the Consolidated Statements of Earnings on a fair value hedge (in thousands):
 
Three Months Ended
Gains (Losses)
February 28, 2017
 
February 29, 2016
Interest rate swaps
$
(4,609
)
 
$

Long-term debt
5,405

 

Total
$
796

 
$

The following table presents unrealized and realized gains (losses) on derivative contracts recognized in Principal transactions revenue in the Consolidated Statements of Earnings, which are utilized in connection with our client activities and our economic risk management activities (in thousands):
 
Three Months Ended
Gains (Losses)
February 28, 2017
 
February 29, 2016
Interest rate contracts
$
9,997

 
$
(72,525
)
Foreign exchange contracts
2,008

 
1,589

Equity contracts
(169,116
)
 
(225,666
)
Commodity contracts
(511
)
 
(1,875
)
Credit contracts
12,041

 
(12,889
)
Total
$
(145,581
)
 
$
(311,366
)

The net gains (losses) on derivative contracts in the table above are one of a number of activities comprising our business activities and are before consideration of economic hedging transactions, which generally offset the net gains (losses) included above. We substantially mitigate our exposure to market risk on our cash instruments through derivative contracts, which generally provide offsetting revenues, and we manage the risk associated with these contracts in the context of our overall risk management framework.
OTC Derivatives. The following tables set forth by remaining contract maturity the fair value of OTC derivative assets and liabilities at February 28, 2017 (in thousands):
 
OTC Derivative Assets (1) (2) (3)
 
0 – 12 Months
 
1 – 5 Years
 
Greater Than 5 Years
 
Cross-Maturity Netting (4)
 
Total
Equity swaps and options
$
18,536

 
$
3,271

 
$

 
$

 
$
21,807

Credit default swaps

 
14,487

 

 

 
14,487

Total return swaps
6,384

 
771

 

 
(38
)
 
7,117

Foreign currency forwards, swaps and options
37,502

 
37,500

 

 
(13,111
)
 
61,891

Interest rate swaps, options and forwards
32,212

 
153,246

 
124,873

 
(66,627
)
 
243,704

Total
$
94,634

 
$
209,275

 
$
124,873

 
$
(79,776
)
 
349,006

Cross product counterparty netting
 
 
 
 
 
 
 
 
(1,512
)
Total OTC derivative assets included in Financial instruments owned
 
 
 
 
 
 
 
 
$
347,494

(1)
At February 28, 2017, we held exchange-traded derivative assets and other credit agreements with a fair value of $15.5 million, which are not included in this table.
(2)
OTC derivative assets in the table above are gross of collateral received. OTC derivative assets are recorded net of collateral received on the Consolidated Statements of Financial Condition. At February 28, 2017, cash collateral received was $176.5 million.
(3)
Derivative fair values include counterparty netting within product category.
(4)
Amounts represent the netting of receivable balances with payable balances for the same counterparty within product category across maturity categories.
 
OTC Derivative Liabilities (1) (2) (3)
 
0 – 12 Months
 
1 – 5 Years
 
Greater Than 5 Years
 
Cross-Maturity Netting (4)
 
Total
Equity swaps and options
$
13,148

 
$
17,187

 
$
1,908

 
$

 
$
32,243

Credit default swaps
178

 
13,155

 

 

 
13,333

Total return swaps
20,221

 
2,391

 

 
(38
)
 
22,574

Foreign currency forwards, swaps and options
39,883

 
27,382

 

 
(13,111
)
 
54,154

Fixed income forwards
275

 

 

 

 
275

Interest rate swaps, options and forwards
19,346

 
92,177

 
96,958

 
(66,627
)
 
141,854

Total
$
93,051

 
$
152,292

 
$
98,866

 
$
(79,776
)
 
264,433

Cross product counterparty netting
 
 
 
 
 
 
 
 
(1,512
)
Total OTC derivative liabilities included in Financial instruments sold, not yet purchased
 
 
 
 
 
 
 
 
$
262,921

(1)
At February 28, 2017, we held exchange-traded derivative liabilities and other credit agreements with a fair value of $254.9 million, which are not included in this table.
(2)
OTC derivative liabilities in the table above are gross of collateral pledged. OTC derivative liabilities are recorded net of collateral pledged on the Consolidated Statements of Financial Condition. At February 28, 2017, cash collateral pledged was $144.2 million.
(3)
Derivative fair values include counterparty netting within product category.
(4)
Amounts represent the netting of receivable balances with payable balances for the same counterparty within product category across maturity categories.
At February 28, 2017, the counterparty credit quality with respect to the fair value of our OTC derivatives assets was as follows (in thousands):
Counterparty credit quality (1):
 
A- or higher
$
218,007

BBB- to BBB+
62,994

BB+ or lower
28,130

Unrated
38,363

Total
$
347,494

(1)
We utilize internal credit ratings determined by our Risk Management department. Credit ratings determined by Risk Management use methodologies that produce ratings generally consistent with those produced by external rating agencies.
Contingent Features
Certain of our derivative instruments contain provisions that require our debt to maintain an investment grade credit rating from each of the major credit rating agencies. If our debt were to fall below investment grade, it would be in violation of these provisions and the counterparties to the derivative instruments could request immediate payment or demand immediate and ongoing full overnight collateralization on our derivative instruments in liability positions. The aggregate fair value of all derivative instruments with such credit-risk-related contingent features that are in a liability position at February 28, 2017 and November 30, 2016 is $19.4 million and $70.6 million, respectively, for which we have received collateral of $3.7 million and posted collateral of $44.4 million, respectively, in the normal course of business. If the credit-risk-related contingent features underlying these agreements were triggered on February 28, 2017 and November 30, 2016, we would have been required to post an additional $23.1 million and $26.1 million, respectively, of collateral to our counterparties.